¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀåÀº 2024³â 7¾ï 9,690¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 11¾ï 900¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2031³â ¿¬Æò±Õ 4.8%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§ |
º¸°í¼ »ó¼¼ |
±âÁØ ¿¬µµ |
2023³â |
2024³â ½ÃÀå ±Ô¸ð |
7¾ï 9,690¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2019-2023³â |
¿¹Ãø ±â°£ |
2024-2031³â |
¿¹Ãø ±â°£ 2024-2031³â CAGR |
4.80% |
2031³â ±Ý¾× Àü¸Á |
11¾ï 900¸¸ ´Þ·¯ |
±×¸². ±Þ¼Ó ÁÖÀԱ⠽ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â

¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀåÀº Áö³ ¸î ³â µ¿¾È ¿Ü»ó Áõ°¡¿Í Ç÷¾× ¹× ¼ö¾×À» ºü¸£°Ô ÁÖÀÔÇØ¾ß ÇÏ´Â ¿Ü°ú ¼ö¼úÀÇ Áõ°¡·Î ÀÎÇØ ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ±Þ¼Ó ÁÖÀÔ±â´Â ȯÀÚ¿¡°Ô Ç÷¾×/¼ö¾×À» Á¦¾îµÈ ¼Óµµ·Î ºü¸£°Ô ÁÖÀÔÇÒ ¼ö ÀÖ´Â ÈÞ´ë¿ë ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ±Þ¼Ó ÁÖÀÔ±â´Â Ç÷¾×·® °¨¼Ò¼º ¼îÅ© ȯÀÚ¿¡°Ô ÃÖÁ¾ Ä¡·á°¡ ÀÌ·ç¾îÁú ¶§±îÁö ÀûÀýÇÑ ¼øÈ¯·®À» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ½ÃÁß¿¡´Â ±â°è½Ä ±Þ¼Ó ÁÖÀÔ±â, ¼öµ¿½Ä ±Þ¼Ó ÁÖÀÔ ÆßÇÁ µî ´Ù¾çÇÑ À¯ÇüÀÇ ±Þ¼Ó ÁÖÀԱⰡ ½ÃÆÇµÇ°í ÀÖ½À´Ï´Ù. ±Þ¼Ó ÁÖÀÔ±âÀÇ ÁÖ¿ä ÀåÁ¡Àº ÀÇ·á Àü¹®°¡°¡ ÀÀ±Þ »óȲ¿¡¼ ȯÀÚ¸¦ ½Å¼ÓÇÏ°Ô ¼Ò»ý½ÃŰ´Â µ¥ µµ¿òÀ̵ȴٴ °ÍÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ:
¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀåÀº ¿Ü»ó, ÃâÇ÷, Àç³ ¹× ºÐÀïÀ¸·Î ÀÎÇÑ »ç»óÀÚ Áõ°¡·Î ÀÎÇØ Áö³ ¸î ³â µ¿¾È ´«¿¡ ¶ç°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ÃßÁ¤¿¡ µû¸£¸é, ±³Åë»ç°í·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â Àü ¼¼°èÀûÀ¸·Î ¿¬°£ 130¸¸ ¸í ÀÌ»óÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ºÎ»ó·üÀÇ Áõ°¡´Â ÀÇ·á ÀÀ±Þ »óȲ¿¡¼ ½Å¼ÓÇÑ Ç÷¾×·® º¸ÃæÀÇ Çʿ伺À» Áõ°¡½ÃÄÑ ±Þ¼Ó ¼ö¾× ÁÖÀÔ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼Òȱâ, ½ÉÇ÷°ü, Á¤Çü¿Ü°ú µî ¿Ü°ú ¼ö¼úÀÇ º¹À⼺ÀÌ Áõ°¡ÇÏ¸é¼ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. ¼±Áø±¹°ú ½ÅÈï±¹ ¸ðµÎ¿¡¼ ÀÇ·áºñ ÁöÃâÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ÈûÀ» º¸Å°í ÀÖ½À´Ï´Ù. ±×·¯³ª ±Þ¼Ó ÁÖÀÔ±â´Â ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ ƯÈ÷ °¡°Ý¿¡ ¹Î°¨ÇÑ °³¹ßµµ»ó±¹¿¡¼´Â º¸±Þ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠ°³¹ßµµ»ó±¹¿¡¼´Â ±Þ¼Ó ÁÖÀԱ⿡ ´ëÇÑ ÀνÄÀÌ ³·´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀÔ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí, º¸´Ù È¿À²ÀûÀ̰í ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ ±Þ¼Ó ÁÖÀԱ⠽ýºÅÛÀ» °³¹ßÇϱâ À§ÇÑ ±â¼ú ¹ßÀüÀÌ °è¼ÓµÇ°í ÀÖ¾î ½ÃÀå Âü¿©Àڵ鿡°Ô Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- ÀÌ º¸°í¼´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ÅëÇØ ¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.
- ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
- ȸ»ç ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
- ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
- ¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
- ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ±Þ¼Ó ÁÖÀԱ⠽ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤
Á¦2Àå ½ÃÀå Àü¸Á
- º¸°í¼ ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ¿µÇ⠺м®
- ½ÃÀå µ¿Çâ
- Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
- ±â¼ú °³¿ä
- ±ÔÁ¦ ½Ã³ª¸®¿À
- °¡°Ý ºÐ¼®
- PEST ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ±Þ¼Ó ÁÖÀԱ⠽ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ÀüüÀûÀÎ ¿µÇâ
- Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
- COVID-19½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ±Þ¼Ó ÁÖÀԱ⠽ÃÀå, Á¦Ç° À¯Çüº°, 2019-2031³â(100¸¸ ´Þ·¯)
- ¼Ò°³
- ÇÚµåÇïµå µð¹ÙÀ̽º
- Æ®·Ñ¸® žÀçÇü µð¹ÙÀ̽º
Á¦6Àå ¼¼°èÀÇ ±Þ¼Ó ÁÖÀԱ⠽ÃÀå, ¿ëµµº°, 2019-2031³â(100¸¸ ´Þ·¯)
- ¼Ò°³
- ¿Ü»ó°ú ±ä±Þ
- ¸¶Ãë
- ¿Ü°ú Ä¡·á
- Ãâ»ê°ú ºÐ¸¸
- ÁýÁß Ä¡·á
- ±âŸ
Á¦7Àå ¼¼°èÀÇ ±Þ¼Ó ÁÖÀԱ⠽ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(100¸¸ ´Þ·¯)
- ¼Ò°³
- º´¿ø
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- Àü¹® Ŭ¸®´Ð
- ±âŸ
Á¦8Àå ¼¼°èÀÇ ±Þ¼Ó ÁÖÀԱ⠽ÃÀå, Áö¿ªº°, 2019-2031³â(100¸¸ ´Þ·¯)
Á¦9Àå °æÀï »óȲ
- ±â¾÷ °³¿ä
- Belmont Medical Technologies
- Stryker Corporation
- ICU Medical, Inc.
- Fresenius Kabi
- ZOLL Medical Corporation
- 410 Medical
- Ace-medical
- Biegler GmbH
- Terumo Corporation y
- Teleflex Incorporated
- BD
- Smisson-Cartledge Biomedical
- 3M Health Care
- Shenzhen Keborui Electronics Co., Ltd
Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×
- À¶¼º°ú ¼èÅð
- Coherent Opportunity Map
Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý
ksm 24.05.28
Global rapid infuser market is estimated to be valued at USD 796.9 Mn in 2024 and is expected to reach USD 1,109 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.
Report Coverage |
Report Details |
Base Year: |
2023 |
Market Size in 2024: |
US$ 796.9 Mn |
Historical Data for: |
2019 to 2023 |
Forecast Period: |
2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: |
4.80% |
2031 Value Projection: |
US$ 1,109 Mn |
Figure. Rapid Infuser Market Share (%), By Region 2024

Global rapid infuser market has been witnessing steady growth over the past few years due to increasing prevalence of trauma cases and rising number of surgical procedures that require rapid infusion of blood or fluid. Rapid infuser is a portable medical device that allows controlled and rapid infusion of blood/fluids into a patient. It helps to maintain adequate circulating volume in patients suffering from hypovolemic shock till definitive care is provided. Various types of rapid infusers are available in the market including mechanical rapid infusers and manual rapid infusion pumps. The key advantage of rapid infusers is that it helps healthcare professionals to resuscitate patients swiftly in emergency conditions.
Market Dynamics:
Global rapid infuser market has been witnessing growth considerably over the past few years due to rising incidence of trauma injuries, hemorrhage cases, and casualties during disasters and conflicts. As per World Health Organization estimates, road accidents account for over 1.3 million casualties annually worldwide. Growing prevalence of such injuries has boosted need for rapid blood volume replacement during medical emergencies, fueling demand for rapid infusers. Moreover, increasing complexity of surgical procedures such as gastrointestinal, cardiovascular, and orthopedic surgeries has accelerated the market growth. Growing healthcare expenditure across both developed and developing nations is also supporting the market expansion. However, the high costs associated with rapid infusers may hinder their widespread adoption, especially in price-sensitive developing regions. The lack of awareness about these devices in some underdeveloped countries further restrain the market growth. Nevertheless, ongoing technological advancements to develop more efficient and affordable rapid infuser systems is expected to create significant growth opportunities for market players.
Key Features of the Study:
- This report provides in-depth analysis of the global rapid infuser market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global rapid infuser market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Belmont Medical Technologies, Stryker Corporation, ICU Medical, Inc., Fresenius Kabi, ZOLL Medical Corporation, 410 Medical, Ace-medical, Biegler GmbH, Terumo Corporation, Teleflex Incorporated, BD, Smisson-Cartledge Biomedical, Fresenius Kabi, 3M Health Care, and Shenzhen Keborui Electronics Co., Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global rapid infuser market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid infuser market
Detailed Segmentation-
- Product Type:
- Handheld Devices
- Trolley Mounted Devices
- Application:
- Trauma & Emergency
- Anesthesia
- Surgical Care
- Labor & Delivery
- Intensive Care
- Others
- End User:
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Others
- Company Profiles:
- Belmont Medical Technologies
- Stryker Corporation
- ICU Medical, Inc.
- Fresenius Kabi
- ZOLL Medical Corporation
- 410 Medical
- Ace-medical
- Biegler GmbH
- Terumo Corporation
- Teleflex Incorporated
- BD
- Smisson-Cartledge Biomedical
- Fresenius Kabi
- 3M Health Care
- Shenzhen Keborui Electronics Co., Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Rapid Infuser Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Rapid Infuser Market, By Product Type, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Handheld Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Trolley Mounted Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Rapid Infuser Market, By Application, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Trauma & Emergency
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Anesthesia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Surgical Care
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Labor & Delivery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Intensive Care
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Rapid Infuser Market, By End User, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Rapid Infuser Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Belmont Medical Technologies*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stryker Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ICU Medical, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fresenius Kabi
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ZOLL Medical Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 410 Medical
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ace-medical
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biegler GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation y
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teleflex Incorporated
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BD
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Smisson-Cartledge Biomedical
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 3M Health Care
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Shenzhen Keborui Electronics Co., Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact